Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00060
http://purl.obolibrary.org/obo/dinto_DB00060
|
|---|---|
| Preferred Name | interferon beta-1a |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | interferon beta-1a
|
|---|---|
| label | interferon beta-1a
|
| DBSynonym |
interferon beta precursor
ifn-beta
fibroblast interferon
|
| ATCCode |
L03AB07
L04AA23
|
| Definition | Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence of Avonex is identical to that of natural human interferon beta.
|
| has pharmacological target | |
| activates | |
| type | |
| AHFScode | 92:00.00
|
| xref |
National Drug Code Directory:44087-8822-1
GenBank:V00534
UniProtKB:P01574
Wikipedia:http://en.wikipedia.org/wiki/Interferon_beta-1a
Drugs Product Database (DPD):2237319
RxList:http://www.rxlist.com/cgi/generic3/rebif.htm
Drugs.com:http://www.drugs.com/cdi/interferon-beta-1a.html
PharmGKB:PA450037
See more
See less
|
| CASRN | 145258-61-3
|
| prefixIRI | obo2:dinto_DB00060
|
| related with | |
| DBBrand |
avonex
avonex (biogen inc)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |